EP 1225903 A2 20020731 - AMINOALKYLENEPHOSPHONATES FOR TREATMENT OF BONE DISORDERS
Title (en)
AMINOALKYLENEPHOSPHONATES FOR TREATMENT OF BONE DISORDERS
Title (de)
AMINOALKYLENEPHOSPHONATEN ZUR BEHANDLUNG VON KNOCHENSTÖRUNGEN
Title (fr)
AMINOALKYLENEPHOSPHONATES DESTINES AU TRAITEMENT DE MALADIES OSSEUSES
Publication
Application
Priority
- US 0028713 W 20001017
- US 16001999 P 19991018
Abstract (en)
[origin: WO0128567A2] A method for preventing or minimizing loss of bone mineral in mammals which method comprises administering to a mammal an amount of an aminoalkylenephosphonate which is effective to prevent or minimize loss of bone mineral density. The aminoalkylenephosphonates of the present invention should have at least one R-N(Alk-PO3H2)2 group or at least two RR´N-Alk-PO3H2 groups wherein R and R´ can be, same or different, aliphatic or cyclic moiety, and Alk is an alkylene group having from 1 to 4 carbon atoms.
IPC 1-7
IPC 8 full level
A61K 31/663 (2006.01); A61K 31/662 (2006.01); A61K 31/675 (2006.01); A61K 31/685 (2006.01); A61P 3/14 (2006.01); A61P 19/00 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01)
CPC (source: EP)
A61K 31/662 (2013.01); A61K 31/675 (2013.01); A61K 31/685 (2013.01); A61P 3/14 (2017.12); A61P 19/00 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12)
Citation (search report)
See references of WO 0128567A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0128567 A2 20010426; WO 0128567 A3 20011129; AU 1092601 A 20010430; CA 2382877 A1 20010426; CN 1378454 A 20021106; EP 1225903 A2 20020731; JP 2003512331 A 20030402
DOCDB simple family (application)
US 0028713 W 20001017; AU 1092601 A 20001017; CA 2382877 A 20001017; CN 00814123 A 20001017; EP 00972234 A 20001017; JP 2001531397 A 20001017